Limited monoclonal antibody therapy guidelines

Demand for monoclonal antibody (mAb) therapy has exceeded capacity at BJC’s clinics. To triage patients, orders will be limited to qualifying high-risk patients who have a positive COVID-19 test. Clinics will cease accepting patients for post-exposure prophylaxis at this time. For information on mAb antibody eligibility and ordering, please visit the BJC website.